An infection, by contrast, is the invasion of and replication in the body by any of various microbial agents—including bacteria, viruses, fungi, protozoans, and worms as well as the reaction of tissues to their presence or to the toxins that they produce.
Approximately 80% of the DT104 isolates were multidrug resistant (MR DT104), i.e., resistant to at least 5 microbial agents, including ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline.
Microbial agents, including environmental microbes and commensal bacteria in the gut, can modulate the severity of AA in certain rat strains.
Although much attention is focused on resistance patterns of eubacteria (6 ), resistance is being found for virtually all microbial agents including mycobacteria (7, 8 ), viruses (9, 10 ), parasites (11, 12 ), and fungi (13, 14 ).
Splenic rupture has been reported in the course of infection with several microbial agents, including Epstein-Barr virus (2 ), HIV, rubella virus, Bartonella spp. (3 ), Salmonella spp., mycobacteria (4 ), and Plasmodium spp. (5 ).
This microorganism can cause localized or disseminated infections that can be life-threatening without prompt diagnosis and proper treatment; furthermore, it is characteristically resistant to multiple anti-microbial agents, including third-generation cephalosporin [ 1, 11].
Past research has demonstrated the potential efficacy of a range of microbial control agents, including bacteria, fungi, nematodes, and viruses.
Most of these genes find utility through transgenic plants, but others find application in improving the performance of different biocontrol agents including microbial species and natural enemies.
Although multiple candidate etiologic agents including microbial organisms and environmental agents have been identified, the results are inconclusive thus far.
Necroptosis, also known as programmed necrosis, can be initiated by various agents including microbial infection, and is characterized by activation of the receptor-interacting protein (RIP) kinases RIP1 and RIP3-dependent signaling pathway.
